Dataset Information


Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment.

ABSTRACT: The mechanisms of Myc-driven liver tumorigenesis are inadequately understood. Herein we show that Myc-driven hepatocellular carcinoma (HCC) is dramatically aggravated in mice with hepatocyte-specific Ptpn11/Shp2 deletion. However, Myc-induced tumors develop selectively from the rare Shp2-positive hepatocytes in Shp2-deficent liver, and Myc-driven oncogenesis depends on an intact Ras-Erk signaling promoted by Shp2 to sustain Myc stability. Despite a stringent requirement of Shp2 cell autonomously, Shp2 deletion induces an immunosuppressive environment, resulting in defective clearance of tumor-initiating cells and aggressive tumor progression. The basal Wnt/β-catenin signaling is upregulated in Shp2-deficient liver, which is further augmented by Myc transfection. Ablating Ctnnb1 suppresses Myc-induced HCC in Shp2-deficient livers, revealing an essential role of β-catenin. Consistently, Myc overexpression and CTNNB1 mutations are frequently co-detected in HCC patients with poor prognosis. These data elucidate complex mechanisms of liver tumorigenesis driven by cell-intrinsic oncogenic signaling in cooperation with a tumor-promoting microenvironment generated by disrupting the specific oncogenic pathway.

PROVIDER: S-EPMC8656042 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6008184 | BioStudies
| S-EPMC5906147 | BioStudies
| S-EPMC6677618 | BioStudies
| S-EPMC8435276 | BioStudies
| S-EPMC8217095 | BioStudies
| S-EPMC7268324 | BioStudies
| S-EPMC4631511 | BioStudies
| S-EPMC4300253 | BioStudies
| S-EPMC5777711 | BioStudies
| S-EPMC3209649 | BioStudies